ICU Medical Inc., a prominent leader in medical device innovation, has announced a new joint venture with Otsuka Pharmaceutical Factory, Inc., a subsidiary of Otsuka Holdings Co., Ltd. The collaboration, named Otsuka ICU Medical LLC, aims to enhance the IV solutions market in North America by leveraging a global manufacturing network. This partnership promises to deliver increased supply chain resiliency and introduce innovative PVC-free technologies to the market. With production spanning 16 sites across Asia and strong North American operations in Austin, Texas, the joint venture is expected to produce 1.4 billion annual units, offering significant economic and clinical value to customers.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。